Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum Cobalamin

This study has been completed.
Information provided by:
Emisphere Technologies, Inc. Identifier:
First received: March 4, 2011
Last updated: March 9, 2011
Last verified: March 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):